Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Biagio De Angelis

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|May 23, 2019
Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell KillingTiziano Ingegnere, Francesca Romana Mariotti, Andrea Pelosi, et al.
Frontiers in Immunology|February 15, 2021
Identification of New Soluble Factors Correlated With the Development of Graft Failure After Haploidentical Hematopoietic Stem Cell TransplantationGerrit Weber, Luisa Strocchio, Francesca Del Bufalo, et al.
Molecular Oncology|September 18, 2021
PD-1-induced T cell exhaustion is controlled by a Drp1-dependent mechanismLuca Simula, Ylenia Antonucci, Giorgia Scarpelli, et al.
Blood|April 21, 2009
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor modelAntonio Di Stasi, Biagio De Angelis, Cliona M Rooney, et al.
NPJ Precision Oncology|August 20, 2025
GD2: hopes and challenges for the treatment of pediatric patients with tumors of the central nervous systemAlba Clara Fernández-Rilo, Emmanuel de Billy, Giada Del Baldo, et al.
Blood|September 18, 2009
Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)Biagio De Angelis, Gianpietro Dotti, Concetta Quintarelli, et al.
Cancer Research|December 1, 2019
Transcription Factors Involved in Tumorigenesis Are Over-Represented in Mutated Active DNA-Binding Sites in NeuroblastomaMario Capasso, Vito Alessandro Lasorsa, Flora Cimmino, et al.
Oncotarget|August 31, 2015
WT1-mediated repression of the proapoptotic transcription factor ZNF224 is triggered by the BCR-ABL oncogeneGiorgia Montano, Karina Vidovic, Chiara Palladino, et al.
Oncoimmunology|January 4, 2018
Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical modelPaola Bocca, Emma Di Carlo, Ignazio Caruana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2012
Interleukin 15 provides relief to CTLs from regulatory T cell-mediated inhibition: implications for adoptive T cell-based therapies for lymphomaSerena K Perna, Biagio De Angelis, Daria Pagliara, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|May 23, 2019
Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell KillingTiziano Ingegnere, Francesca Romana Mariotti, Andrea Pelosi, et al.
Frontiers in Immunology|February 15, 2021
Identification of New Soluble Factors Correlated With the Development of Graft Failure After Haploidentical Hematopoietic Stem Cell TransplantationGerrit Weber, Luisa Strocchio, Francesca Del Bufalo, et al.
Molecular Oncology|September 18, 2021
PD-1-induced T cell exhaustion is controlled by a Drp1-dependent mechanismLuca Simula, Ylenia Antonucci, Giorgia Scarpelli, et al.
Blood|April 21, 2009
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor modelAntonio Di Stasi, Biagio De Angelis, Cliona M Rooney, et al.
NPJ Precision Oncology|August 20, 2025
GD2: hopes and challenges for the treatment of pediatric patients with tumors of the central nervous systemAlba Clara Fernández-Rilo, Emmanuel de Billy, Giada Del Baldo, et al.
Blood|September 18, 2009
Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)Biagio De Angelis, Gianpietro Dotti, Concetta Quintarelli, et al.
Cancer Research|December 1, 2019
Transcription Factors Involved in Tumorigenesis Are Over-Represented in Mutated Active DNA-Binding Sites in NeuroblastomaMario Capasso, Vito Alessandro Lasorsa, Flora Cimmino, et al.
Oncotarget|August 31, 2015
WT1-mediated repression of the proapoptotic transcription factor ZNF224 is triggered by the BCR-ABL oncogeneGiorgia Montano, Karina Vidovic, Chiara Palladino, et al.
Oncoimmunology|January 4, 2018
Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical modelPaola Bocca, Emma Di Carlo, Ignazio Caruana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2012
Interleukin 15 provides relief to CTLs from regulatory T cell-mediated inhibition: implications for adoptive T cell-based therapies for lymphomaSerena K Perna, Biagio De Angelis, Daria Pagliara, et al.
Pageof 7